{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:42:03Z","timestamp":1747172523186,"version":"3.40.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technological Development","award":["175024"],"award-info":[{"award-number":["175024"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.yexmp.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T13:51:58Z","timestamp":1529675518000},"page":"115-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlation between PAI-1, leptin and ferritin with HOMA in HIV\/AIDS patients"],"prefix":"10.1016","volume":"105","author":[{"given":"Gordana","family":"Dragovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-6650","authenticated-orcid":false,"given":"Mirjana","family":"Sumarac-Dumanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al Musalhi","family":"Khawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Soldatovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mladen","family":"Andji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djordje","family":"Jevtovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devaki","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2018.06.004_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12981-015-0065-8","article-title":"Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women","volume":"12","author":"Abrahams","year":"2015","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000339201","article-title":"Relationship between leptin levels and suppressed CD4 counts in HIV patients","volume":"22","author":"Al-Fadhli","year":"2013","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0020","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/1078-0432.CCR-06-2416","article-title":"Vascular endothelial growth factor and its relationship to inflammatory mediators","volume":"13","author":"Angelo","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157016206775197664","article-title":"Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection","volume":"4","author":"Barbaro","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/1520-7560(200005\/06)16:3<192::AID-DMRR114>3.0.CO;2-G","article-title":"Relationship between plasma activator inhibitor 1 and insulin resistance","volume":"16","author":"Bastard","year":"2000","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0035","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/ATVBAHA.107.160168","article-title":"Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy","volume":"28","author":"Brazionis","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0040","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"CDC","year":"1992","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0050","first-page":"286","article-title":"Clinical profile of metabolic syndrome with reference to insulin resistance (HOMA-IR)","volume":"13","author":"Chaudhari","year":"2012","journal-title":"JIACM"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3904\/kjim.2012.27.1.66","article-title":"Associations among body mass index, insulin resistance, and pancreatic \u03b2-cell function in Korean patients with new-onset type 2 diabetes","volume":"27","author":"Chung","year":"2012","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1538-7836.2004.00602.x","article-title":"Insulin resistance status is an important determinant of PAI-1 levels in HIV-infected patients, independently of the lipid profile","volume":"2","author":"De Larranga","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0065","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1159\/000081058","article-title":"Anemia and diabetes","volume":"24","author":"Deray","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0075","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1515\/CCLM.2007.259","article-title":"Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-methabolic and metabolic syndrome","volume":"45","author":"Dimitrijevic-Sreckovic","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0753-3322(01)00068-3","article-title":"Iron metabolism, free radicals, and oxidative injury","volume":"55","author":"Emerit","year":"2001","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1665-2681(19)31518-2","article-title":"Plasminogen activator inhibitor type 1 serum levels and 4g\/5g gene polymorphism in morbidity obese Hispanic patients with non-alcoholic fatty liver disease","volume":"10","author":"Espino","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0095","first-page":"119","article-title":"Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease","volume":"6","author":"Forood","year":"2014","journal-title":"Addict. Health"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0100","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1172\/JCI44421","article-title":"Adipocytes iron regulates adiponectin and insulin sensitivity","volume":"122","author":"Gabrielsen","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00431-010-1370-9","article-title":"Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters","volume":"170","author":"Galli-Tsinopoulou","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0110","first-page":"672","article-title":"Leptin reference values and cutoffs for identifying cardiometabolic abnormalities in the Spanish population","volume":"68","author":"Gijon-Conde","year":"2015","journal-title":"Rev. Esp. Cardiol. (Eng Ed)"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059768","article-title":"Changing mortality profile among HIV infected patients in Rio de Jeneiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era","volume":"8","author":"Grinsztejn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0120","first-page":"382","article-title":"Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy","volume":"63","author":"Guzman-Fulgenacio","year":"2011","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jcsm.12283","article-title":"HmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway","volume":"9","author":"Halon- Golabek","year":"2018","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0130","doi-asserted-by":"crossref","first-page":"1700036","DOI":"10.1002\/bies.201700036","article-title":"Inflammation and insulin resistance: new targets new thinking: Galectin-3 and LTB4 are pro-inflammatory moleculesthat can be targeted to restore insulin sensitivity","volume":"39","author":"Johnson","year":"2017","journal-title":"BioEssays"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0135","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product form demaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002335","article-title":"Serum ferritin levels are positively associated with metabolically obese normal weight: A national population- based study","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2005.00271.x","article-title":"Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003","volume":"6","author":"Krentz","year":"2005","journal-title":"HIV Med."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0150","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1432-1033.2003.03453.x","article-title":"Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding","volume":"270","author":"Lopez-Alemany","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.aids.0000199824.26618.62","article-title":"Hyperglycosylated ferritin in sera of HIV-1-infected patients treated with highly antiretroviral therapy","volume":"20","author":"Malvoisin","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0160","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0165","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/dc09-1392","article-title":"Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance","volume":"33","author":"Mente","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0170","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s10620-013-2648-3","article-title":"Iron overload causes oxidative stress and impaired insulin signaling in AML 12 hepatocytes","volume":"58","author":"Messner","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006622","article-title":"Serum resistin positively correlates with serum lipids but not with insulin resistance, in first-degree relatives of type-2 diabetes patients: an observational study in China","volume":"96","author":"Niu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2334-11-40","article-title":"Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir","volume":"11","author":"Padilla","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0190","first-page":"11","article-title":"Association of serum ferritin levels with metabolic syndrome and insulin resistance","volume":"9","author":"Padwal","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QAI.0b013e31819c291b","article-title":"Prevalence and pathogenesis of diabetes mellitusin HIV-1 infection treated with combined antiretroviral therapy","volume":"50","author":"Samaras","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0205","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2249.2003.02321.x","article-title":"Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients","volume":"134","author":"S\u00e1nchez-Pozo","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0210","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1172\/JCI115440","article-title":"Regulation of murine type 1 olasminogen activator inhibitor gene expression in vivo. Tissuespecificity and induction by lipopolyaharide, tmr growth factor-alpha, and transforming growth factor-beta","volume":"88","author":"Sawdey","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0215","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.88.22.9959","article-title":"Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states","volume":"88","author":"Shneider","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00431-014-2426-z","article-title":"Relationship between triglyceride levels with the increase of HOMA-IR and HOMA-\u03b2 in healthy children and adolescents with normal weight","volume":"174","author":"Simental-Mendia","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.17306\/J.AFS.2017.0442","article-title":"The genetic basis of obesity complications","volume":"16","author":"Skrypnik","year":"2017","journal-title":"Acta Sci. Pol. Technol. Aliment."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/16546628.2017.1295525","article-title":"Effects of green tea supplementation on inflammation markers, antioxidant status and blood pressure in NaCl-induced hypertensive rat model","volume":"61","author":"Szuli\u0144ska","year":"2017","journal-title":"Food Nutr. Res."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.metabol.2005.08.020","article-title":"Interleukin 6, adiponectin, leptin and insulin resistance in nonobese Japanese type 2 diabetic patients","volume":"55","author":"Taniguchi","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0240","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/diacare.26.4.1164","article-title":"Unrecognized anemia in patients with diabetes: a cross-sectional survey","volume":"26","author":"Thomas","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0245","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adypociytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2018.06.004_bb0250","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ncpgasthep0359","article-title":"The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases","volume":"2005","author":"Vermeire","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenerol. Hepatol."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.hlc.2013.05.161","article-title":"The relationship between high density lipoprotein (HDL) levels and glycaemic control in type 2 diabetes mellitus (T2DM): the FIELD study","volume":"22","author":"Waldman","year":"2013","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0260","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yexmp.2018.06.004_bb0265","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.kjms.2012.08.041","article-title":"Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss","volume":"29","author":"Wang","year":"2013","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0270","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resisatnce","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12291-011-0119-1","article-title":"Correlation of adiponectin and leptin with insulin resistance: a pilot study in healthy north Indian population","volume":"26","author":"Yadav","year":"2011","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.yexmp.2018.06.004_bb0280","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018301576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480018301576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T17:54:03Z","timestamp":1571507643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480018301576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0014480018301576"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2018.06.004","relation":{},"ISSN":["0014-4800"],"issn-type":[{"type":"print","value":"0014-4800"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between PAI-1, leptin and ferritin with HOMA in HIV\/AIDS patients","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}